Impact Factor
4.36
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.62
5,136 total citations
h5-index
81
h5 depth signal
Cited share
69.6%
560 of 805
Total citations
5,136
Citation footprint
Metric signal
6.62
External metric anchor
Self-citation
9.3%
477 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,652
Italy
1,051
United Kingdom
1,020
Germany
921
Netherlands
658
Citing Fields of Research
Cardiology
4,516
Diabetes
341
Auto-Inflammatory Disorders
287
Kidney Diseases
219
Respiratory Support
190
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,683
Articles tracked across the journal lifetime
Indexed publication set
805
560 cited publications
Last 12 months
1,903
158.6 publications/month
Open access share
7.6%
145 OA publications in the last year
Leading citing country
United States
1,652 citing publications
Leading citing field
Cardiology
4,516 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Mar. 1999-
v1n1, Mar. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
European Society of Cardiology. Working Group on Heart Failure
Broad Categories
Cardiology
MeSH Descriptors
Heart Failure
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
Heart transplantation (HTx) remains the gold standard treatment for selected patients with advanced heart failure and survival after transplantation has substantially improved over recent decades. As a consequence, the number of long-ter...
02
03
DOI 10.1093/ejhf/xuag314
Open DOI
Diagnostic Accuracy of NT-proBNP thresholds in Dyspneic Patients in the Emergency Department according to patients’ characteristics: A Systematic Review and Meta-Analysis
Background: Concentrations of N-terminal pro-B type natriuretic peptide (NT-proBNP) is central to acute heart failure (AHF) diagnosis in dyspneic emergency departments (ED) patients, but optimal thresholds remain uncertain. This study ai...
04
DOI 10.1093/ejhf/xuag313
Open DOI
GLP-1 receptor agonist treatment and cardiovascular outcomes following aortic valve replacement: a nationwide observational study
Background: GLP-1 receptor agonists reduce major adverse cardiovascular events among patients with diabetes, overweight, and obesity. Whether these benefits extend to patients undergoing aortic valve replacement (AVR) for severe aortic s...
05
DOI 10.1093/ejhf/xuag318
Open DOI
Sex-Based Differences in Chronic Heart Failure: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Sex-based disparities in patient enrollment and treatment effects in heart failure (HF) randomized controlled trials (RCTs) have been reported. We aim to systematically analyze sex-based enrollment and treatment effect differ...
06
DOI 10.1093/ejhf/xuag322
Open DOI
Evaluating the Role of Lower Extremity Elastic Bandage in Patients with Acute Decompensated Heart Failure
Background: Lower extremity compression therapy has been proposed as an adjunct to mitigate diuretic resistance during acute decompensation of heart failure (ADHF). We evaluated the effect of lower leg compression with elastic bandages o...
07
DOI 10.1093/ejhf/xuag319
Open DOI
Pulse pressure in heart failure – easy to assess, not so easy to understand
08
09
DOI 10.1093/ejhf/xuag315
Open DOI
Underserved communities at risk of heart failure: effectiveness of community-based recruitment strategies and burden of unrecognised cardiovascular disease
Background: Patients from socioeconomically deprived and ethnically diverse backgrounds are under-represented in cardiovascular research. EARLY-HF is a community-based pilot study designed to predict incident HF in primary care. We aimed...
10
DOI 10.1093/ejhf/xuag317
Open DOI
“Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres”
Background: The Global Registries and Surveys Programme–Heart Failure (GRASP-HF) is a prospective, multicentre, international observational study assessing implementation of the 2021/2023 ESC-HF-Guidelines. GRASP-HF is aligned with the I...
Bibliographical & Catalog Notes
Imprint varies.
Electronic access restricted to onsite only.
Also issued online.
Affiliated with: ESC heart failure 2055-5822 (DLC) 2015243402 (OCoLC)899737447 (DNLM)101669191.
v. 1, no. 1 (1999)20000807 Notice not published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper